Feedback

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

Affiliation
Division of Psychopharmacology ,Department of Pharmacy ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
Guo, Haoning;
Affiliation
Clinical Experimental Center ,Jiangmen Central Hospital ,Affiliated Jiangmen Hospital of Sun Yat-Sen University ,Jiangmen ,China
Wang, Bin;
Affiliation
Division of Psychopharmacology ,Department of Pharmacy ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
Yuan, Shuying;
Affiliation
Division of Psychopharmacology ,Department of Pharmacy ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
Wu, Silin;
Affiliation
Department of Pathology ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
Liu, Jing;
Affiliation
Division of Psychopharmacology ,Department of Pharmacy ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
He, Miaoquan;
Affiliation
Division of Psychopharmacology ,Department of Pharmacy ,The Third Hospital of Mianyang ,Sichuan Mental Health Center ,Mianyang ,China
Wang, Jisheng

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2022 Guo, Wang, Yuan, Wu, Liu, He and Wang.

Use and reproduction: